The Scientist

» drug development, ecology, evolution and immunology

Most Recent

By analyzing the genomes of 161 dog breeds, scientists discover how and when certain canine breeds emerged.

0 Comments

The state’s board of education approves new standards that ease up on having students dig into scientific issues relevant to “intelligent design” arguments.

1 Comment

image: Migratory Eels Use Magnetoreception

Migratory Eels Use Magnetoreception

By | April 14, 2017

In laboratory experiments that simulated oceanic conditions, the fish responded to magnetic fields, a sensory input that may aid migration.

0 Comments

image: Drugs OKed Faster in U.S. Than in Europe

Drugs OKed Faster in U.S. Than in Europe

By | April 10, 2017

In recent years, the US Food and Drug Administration has approved more drugs and in less time than the European Medicines Agency.

0 Comments

image: Viral Trigger for Celiac Disease?

Viral Trigger for Celiac Disease?

By | April 6, 2017

A common, seemingly benign human virus can trigger an immune response that leads to celiac disease in a mouse model, researchers show. 

3 Comments

image: New Giant Virus Group Reported

New Giant Virus Group Reported

By | April 6, 2017

A genomic analysis of “Klosneuviruses” suggests that they evolved from small viruses that accumulated genetic material over time, but not all virologists are convinced. 

0 Comments

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

image: Gel Scaffolds for Delivery of Immunotherapies

Gel Scaffolds for Delivery of Immunotherapies

By | April 1, 2017

Using biocompatible polymers to carry cancer immune therapies directly to the tumor

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Neoantigens Enable Personalized Cancer Immunotherapy

Neoantigens Enable Personalized Cancer Immunotherapy

By | April 1, 2017

Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.

1 Comment

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS